What I am pointing out (so that there won't be a huge disappointment, like Brainwise, when sales from Levetiracetam are no where near what we hope they would be), is that based on current revenues (the fins based on Sohm's world wide distribution abilities to date ) the SOHM distribution market is very very very small compared to it's competitors.
So, don't expect huge market penetration.( I would love the company to prove me wrong).
But at least it is a start to a new beginning.
News 
Market Data 
Discover 
